Year |
Citation |
Score |
2010 |
Beer S, Bellovin DI, Lee JS, Komatsubara K, Wang LS, Koh H, Börner K, Storm TA, Davis CR, Kay MA, Felsher DW, Grimm D. Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 161-70. PMID 19844192 DOI: 10.1038/Mt.2009.222 |
0.633 |
|
2009 |
Fan AC, Deb-Basu D, Orban MW, Gotlib JR, Natkunam Y, O'Neill R, Padua RA, Xu L, Taketa D, Shirer AE, Beer S, Yee AX, Voehringer DW, Felsher DW. Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nature Medicine. 15: 566-71. PMID 19363496 DOI: 10.1038/Nm.1903 |
0.538 |
|
2008 |
Beer S, Komatsubara K, Bellovin DI, Kurobe M, Sylvester K, Felsher DW. Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis. Plos One. 3: e2493. PMID 18560566 DOI: 10.1371/Journal.Pone.0002493 |
0.646 |
|
2008 |
Kurobe M, Hu M, Beer S, Ghole S, Jeong YJ, Felsher D, Sylvester KG. 162. Oval Cell Expansion Through Wnt Signaling Shortens Tumor Latency During MYC Induced Hepatocarcinogenesis Journal of Surgical Research. 144: 249. DOI: 10.1016/J.Jss.2007.12.185 |
0.559 |
|
2004 |
Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 431: 1112-7. PMID 15475948 DOI: 10.1038/Nature03043 |
0.586 |
|
2004 |
Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW. Developmental context determines latency of MYC-induced tumorigenesis Plos Biology. 2. PMID 15455033 DOI: 10.1371/Journal.Pbio.0020332 |
0.595 |
|
Show low-probability matches. |